BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261020T173000
DTEND;TZID=America/New_York:20261020T200000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Cocktail Reception and Panel Discussion: Value Creation and the Valuation Reset — MedTech Navigates Uncertain Waters
DESCRIPTION:Attending the MedTech Conference in Boston? LEK is hosting cocktails\, networking\, and a distinguished group of panelists. Topic: MedTech has long been valued for its durable growth and attractive margins\, but sector valuations have come under increasing pressure. We're bringing together senior leaders from across the industry for a candid discussion on what's driving the valuation pressure and volatility\, where the next wave of value creation and valuation reset may come from\, as well as the role of the recent wave of special situations such as carve-outs and take-privates. Panel participants include: Matt Dolan: EVP\, Strategy & Corporate Development at Dexcom Rachel Ellingson: Chief Strategy & Corporate Development Officer at Solventum Gabriela Kaynor: Executive Officer & Chief Strategy Officer at Olympus Corporation Vishva Mehta: Principal\, Healthcare & Life Sciences at Blackstone Andr -Michel Ballester: Managing Partner\, MedTech at Archimed Contact: k.stehlik@lek.com for more information and registration
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE html><html><head><title></title></head><body aria-disabled="false"><p>Attending the MedTech Conference in Boston? LEK is hosting cocktails\, networking\, and a distinguished group of panelists. Topic: MedTech has long been valued for its durable growth and attractive margins\, but sector valuations have come under increasing pressure. We&#39\;re bringing together senior leaders from across the industry for a candid discussion on what&#39\;s driving the valuation pressure and volatility\, where the next wave of value creation and valuation reset may come from\, as well as the role of the recent wave of special situations such as carve-outs and take-privates. Panel participants include: Matt Dolan: EVP\, Strategy &amp\; Corporate Development at Dexcom Rachel Ellingson: Chief Strategy &amp\; Corporate Development Officer at Solventum Gabriela Kaynor: Executive Officer &amp\; Chief Strategy Officer at Olympus Corporation Vishva Mehta: Principal\, Healthcare &amp\; Life Sciences at Blackstone Andr&eacute\;-Michel Ballester: Managing Partner\, MedTech at Archimed Contact: k.stehlik@lek.com for more information and registration</p></body></html>
LOCATION:270 Northern Avenue Boston MA 02210
UID:e.1244.1651847
SEQUENCE:3
DTSTAMP:20261008T232746Z
URL:https://massmedic.growthzoneapp.com/events/Details/cocktail-reception-and-panel-discussion-value-creation-and-the-valuation-reset-medtech-navigates-uncertain-waters-1943736?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR